GERI-TUSSIN EXPECTORANT

Product NDC: 57896-793
11-digit product format: 578960793
Labeler code: 57896
Product ID: 57896-793_9a0053c1-98dd-6e43-e053-2995a90acec5
Type: HUMAN OTC DRUG
Nonproprietary name: Guaifenesin
Dosage form: LIQUID
Route: ORAL
Labeler: Geri-Care Pharmaceuticals, Corp
Application: part341
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2000-01-01
Marketing end: 2021-01-31
Substance: GUAIFENESIN
Active strength: 100 mg/5mL
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	57896-793		D	Discontinued by firm		2026-10-05
excluded package	package	57896-793	57896-793-16	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	57896-793-16	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	57896-793-16	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	57896-793-16	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	57896-793-16	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	57896-793-16	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	57896-793-16	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	57896-793-16	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	57896-793-16	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	57896-793-16	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	57896-793-16	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	57896-793-16	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	57896-793-16	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
4fe95224-f543-4dbb-9445-8cca122b48c8	Product name	1	20150609
e8718272-64cb-4436-969b-176c3067c8f4	Product name	1	20150609
106ff02a-57e1-4c4c-a307-fd582ff4e311	Product name	1	20150212

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
57896-793-16	ML - Milliliter	57896-793	899258c7-65d8-4f43-bbd1-1369fc6937e2	1	2013-08-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GUAIFENESIN	ACTIVE INGREDIENT	495W7451VQ	GERI-TUSSIN EXPECTORANT (GUAIFENESIN) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]	1
GUAIFENESIN	ACTIVE MOIETY	495W7451VQ	GERI-TUSSIN EXPECTORANT (GUAIFENESIN) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]	1
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	GERI-TUSSIN EXPECTORANT (GUAIFENESIN) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]	1
CARAMEL	INACTIVE INGREDIENT	T9D99G2B1R	GERI-TUSSIN EXPECTORANT (GUAIFENESIN) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	GERI-TUSSIN EXPECTORANT (GUAIFENESIN) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	GERI-TUSSIN EXPECTORANT (GUAIFENESIN) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]	1
MENTHOL	INACTIVE INGREDIENT	L7T10EIP3A	GERI-TUSSIN EXPECTORANT (GUAIFENESIN) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]	1
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	GERI-TUSSIN EXPECTORANT (GUAIFENESIN) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	GERI-TUSSIN EXPECTORANT (GUAIFENESIN) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]	1
SORBITOL	INACTIVE INGREDIENT	506T60A25R	GERI-TUSSIN EXPECTORANT (GUAIFENESIN) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	GERI-TUSSIN EXPECTORANT (GUAIFENESIN) LIQUID [GERI-CARE PHARMACEUTICALS, CORP]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
495W7451VQ	GUAIFENESIN	93-14-1	GUAIFENESIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310604	guaiFENesin 100 MG in 5 mL Oral Solution	PSN	8d9b270c-faeb-4424-92ef-933ae315f459	3
310604	guaifenesin 20 MG/ML Oral Solution	SCD	8d9b270c-faeb-4424-92ef-933ae315f459	3
310604	guaifenesin 100 MG per 5 ML Oral Solution	SY	8d9b270c-faeb-4424-92ef-933ae315f459	3
310604	guaifenesin 100 MG per 5 ML Oral Syrup	SY	8d9b270c-faeb-4424-92ef-933ae315f459	3
310604	guaifenesin 200 MG per 10 ML Oral Solution	SY	8d9b270c-faeb-4424-92ef-933ae315f459	3
310604	guaifenesin 300 MG per 15 ML Oral Solution	SY	8d9b270c-faeb-4424-92ef-933ae315f459	3
310604	guaifenesin 400 MG per 20 ML Oral Solution	SY	8d9b270c-faeb-4424-92ef-933ae315f459	3

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GERI-TUSSIN EXPECTORANT - Geri-Care Pharmaceuticals, Corp	Geri-Care Pharmaceuticals, Corp	2019-12-18	HUMAN OTC DRUG LABEL	2
GERI-TUSSIN EXPECTORANT - REMEDYREPACK INC.	REMEDYREPACK INC.	2019-03-22	HUMAN OTC DRUG LABEL	1
GERI-TUSSIN EXPECTORANT - Atlantic Biologicals Corps	Atlantic Biologicals Corps	2018-06-20	HUMAN OTC DRUG LABEL	3